Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cancer drug shows promise in slowing rare tumor growth

NCT ID NCT02066181

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 trial tested the drug sorafenib in 87 people with desmoid tumors, a rare type of growth that can be painful and invasive. The study compared sorafenib to a placebo to see if it could slow tumor progression. Sorafenib works by blocking proteins that help tumors grow. The main goal was to see how long patients lived without their disease getting worse.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sorafenib (Nexavar)
What this could lead to
If successful, sorafenib could offer a new treatment option to slow or stop the growth of desmoid tumors, potentially avoiding the need for surgery or other invasive procedures.
What could go wrong
This is a relatively small Phase 3 trial (87 participants), and sorafenib can cause side effects like fatigue, diarrhea, and skin reactions. The drug may not work for everyone, and long-term benefits are still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

87 people

The number who actually took part.

Started

Mar 2014

Finished

Dec 2022

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients must have confirmation of DT/DF by local pathologist prior to registration * Patients may have been treated with locoregional therapies such as major surgery, radiation, radiofrequency ablation, or cryosurgery provided this has been completed at least 4 weeks prior to registration and recovered from therapy related toxicity to less than CTCAE grade 2 * Patients may have been treated with cytotoxic, biologic (antibody), immune or experimental therapy, tyrosine kinase inhibitors, hormone inhibitors or nonsteroidal anti-inflammatory drugs (NSAIDs) provided this has been completed at least 4 weeks prior to registration (6 weeks for mitomycin and nitrosoureas) and recovered from any therapy related toxicity to less than CTCAE grade 2 * Patients with prior or current treatment of sorafenib are excluded * No concomitant treatment, in therapeutic doses, with anticoagulants such as warfarin or warfarin-related agents, heparin, thrombin or Factor Xa inhibitors, or antiplatelet agents (e.g., clopidogrel); low dose aspirin (=\< 81 mg/day), low-dose warfarin (=\< 1 mg/day), and prophylactic low molecular weight heparin (LMWH) are permitted; please note that drugs that strongly induce or inhibit cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) or are associated with a risk of torsades are not allowed; chronic concomitant treatment of CYP3A4 inducers is not allowed (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, and St. John's wort); as part of the enrollment/informed consent procedures, the patient will be counseled on the risk of interactions with other agents, and what to do if new medications need to be prescribed or if the patient is considering a new over-the-counter medicine or herbal product; the following drugs are strong inhibitors of CYP3A4 and are not allowed during the treatment with sorafenib: * Boceprevir * Indinavir * Nelfinavir * Lopinavir/ritonavir * Saquinavir * Telaprevir * Ritonavir * Clarithromycin * Conivaptan * Itraconazole * Ketoconazole * Mibefradil * Nefazodone * Posaconazole * Voriconazole * Telithromycin * Drugs with possible or conditional risk of torsades should be used with caution knowing that sorafenib could prolong the QT interval * Chronic daily NSAID use as treatment for controlling desmoid tumors is not allowed, and should be stopped \>= 3 days prior to registration; NSAIDS are allowed when used for desmoid tumor-related pain or for symptoms that are unrelated to desmoid disease (eg. headache, arthritis) * Patients must have measurable disease * Patients have to meet one of the following criteria to be eligible: * Disease determined unresectable or entailing unacceptably morbid surgery based on 1 or more of the following characteristics: * Multifocal disease * Disease in which there is involvement or inadequate plane from: neurovascular bundle, bone, skin, or viscera * Large size in relationship to location OR multi-compartment involvement * Progression by radiographic imaging (10% increase in size by RECIST v1.1 within 6 months of registration) * Patients with symptomatic disease which meets the following criteria Brief Pain Inventory (BPI) score greater than or equal to 3 AND one of the following: * Inability to control pain with NSAIDs and considering addition of narcotics OR * \> 30% increase in current use of narcotics OR * Addition of a new opioid narcotic * Eastern Cooperative Oncology Group (ECOG) performance status =\< 2 * Patients who are pregnant or nursing are not eligible * No patients with a history of cardiac disease: congestive heart failure \> class II New York Heart Association (NYHA); active coronary artery disease (CAD) (myocardial infarction or unstable angina within 6 months prior to study entry) * No patients with inadequately controlled hypertension (defined as a blood pressure of \>= 150 mmHg systolic and/or \>= 90 mmHg diastolic), or any prior history of hypertensive crisis or hypertensive encephalopathy * No patients with clinically significant gastrointestinal (GI) bleeding or bleeding diathesis within 30 days prior to registration * Absolute neutrophil count \>= 1,500/mm\^3 * Hemoglobin \>= 8 g/dl * Platelets \>= 75,000/mm\^3 * Total bilirubin =\< 1.5 x upper limits of normal (ULN) * Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase \[AST\])/serum glutamate pyruvate transaminase (SGPT) (aspartate aminotransferase \[ALT\]) =\< 1.5 x ULN * Calculated creatinine clearance \>= 50 mL/min using the Cockcroft-Gault equation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Desmoid fibromatosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Abbott-Northwestern Hospital

    Minneapolis, Minnesota, 55407, United States

  • Alegent Health Bergan Mercy Medical Center

    Omaha, Nebraska, 68124, United States

  • Alegent Health Immanuel Medical Center

    Omaha, Nebraska, 68122, United States

  • Alegent Health Lakeside Hospital

    Omaha, Nebraska, 68130, United States

  • Atrium Medical Center-Middletown Regional Hospital

    Franklin, Ohio, 45005-1066, United States

  • Beebe Health Campus

    Rehoboth Beach, Delaware, 19971, United States

  • Beebe Medical Center

    Lewes, Delaware, 19958, United States

  • Blanchard Valley Hospital

    Findlay, Ohio, 45840, United States

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Cancer Center of Western Wisconsin

    New Richmond, Wisconsin, 54017, United States

  • Cancer Therapy and Integrative Medicine

    Las Vegas, Nevada, 89121, United States

  • Cancer and Blood Specialists-Henderson

    Henderson, Nevada, 89052, United States

  • Cancer and Blood Specialists-Shadow

    Las Vegas, Nevada, 89106, United States

  • Cancer and Blood Specialists-Tenaya

    Las Vegas, Nevada, 89128, United States

  • Central Care Cancer Center - Bolivar

    Bolivar, Missouri, 65613, United States

  • Christiana Care Health System-Christiana Hospital

    Newark, Delaware, 19718, United States

  • Christiana Care Health System-Concord Health Center

    Chadds Ford, Pennsylvania, 19317, United States

  • Christiana Care Health System-Wilmington Hospital

    Wilmington, Delaware, 19801, United States

  • Christiana Gynecologic Oncology LLC

    Newark, Delaware, 19713, United States

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada, 89148, United States

  • Comprehensive Cancer Centers of Nevada - Central Valley

    Las Vegas, Nevada, 89169, United States

  • Comprehensive Cancer Centers of Nevada - Henderson

    Henderson, Nevada, 89052, United States

  • Comprehensive Cancer Centers of Nevada - Northwest

    Las Vegas, Nevada, 89128, United States

  • Comprehensive Cancer Centers of Nevada-Southeast Henderson

    Henderson, Nevada, 89074, United States

  • Comprehensive Cancer Centers of Nevada-Summerlin

    Las Vegas, Nevada, 89144, United States

  • Cox Cancer Center Branson

    Branson, Missouri, 65616, United States

  • CoxHealth South Hospital

    Springfield, Missouri, 65807, United States

  • Creighton University Medical Center

    Omaha, Nebraska, 68131, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Dayton NCI Community Oncology Research Program

    Dayton, Ohio, 45459, United States

  • Delaware Clinical and Laboratory Physicians PA

    Newark, Delaware, 19713, United States

  • Delbert Day Cancer Institute at PCRMC

    Rolla, Missouri, 65401, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Fairview Ridges Hospital

    Burnsville, Minnesota, 55337, United States

  • Fairview Southdale Hospital

    Edina, Minnesota, 55435, United States

  • Faith Regional Health Services Carson Cancer Center

    Norfolk, Nebraska, 68701, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, 19111, United States

  • Freeman Health System

    Joplin, Missouri, 64804, United States

  • GenesisCare USA - Fort Apache

    Las Vegas, Nevada, 89148, United States

  • GenesisCare USA - Henderson

    Henderson, Nevada, 89074, United States

  • GenesisCare USA - Las Vegas

    Las Vegas, Nevada, 89109, United States

  • GenesisCare USA - Vegas Tenaya

    Las Vegas, Nevada, 89128, United States

  • Good Samaritan Hospital - Dayton

    Dayton, Ohio, 45406, United States

  • Good Samaritan Regional Health Center

    Mount Vernon, Illinois, 62864, United States

  • Great Plains Health Callahan Cancer Center

    North Platte, Nebraska, 69101, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, 07601, United States

  • Hawaii Cancer Care Inc - Waterfront Plaza

    Honolulu, Hawaii, 96813, United States

  • Hawaii Cancer Care Inc-Liliha

    Honolulu, Hawaii, 96817, United States

  • Health Partners Inc

    Minneapolis, Minnesota, 55454, United States

  • HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills

    Las Vegas, Nevada, 89149, United States

  • HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway

    Las Vegas, Nevada, 89109, United States

  • HealthCare Partners Medical Group Oncology/Hematology-San Martin

    Las Vegas, Nevada, 89113, United States

  • HealthCare Partners Medical Group Oncology/Hematology-Tenaya

    Las Vegas, Nevada, 89128, United States

  • Helen F Graham Cancer Center

    Newark, Delaware, 19713, United States

  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415, United States

  • Huntsman Cancer Institute/University of Utah

    Salt Lake City, Utah, 84112, United States

  • Hutchinson Area Health Care

    Hutchinson, Minnesota, 55350, United States

  • John B Amos Cancer Center

    Columbus, Georgia, 31904, United States

  • Johns Hopkins University/Sidney Kimmel Cancer Center

    Baltimore, Maryland, 21287, United States

  • Kapiolani Medical Center for Women and Children

    Honolulu, Hawaii, 96826, United States

  • Kettering Medical Center

    Kettering, Ohio, 45429, United States

  • Kuakini Medical Center

    Honolulu, Hawaii, 96817, United States

  • Lakeview Hospital

    Stillwater, Minnesota, 55082, United States

  • Las Vegas Cancer Center-Henderson

    Henderson, Nevada, 89052, United States

  • Las Vegas Cancer Center-Medical Center

    Las Vegas, Nevada, 89148-2405, United States

  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler

    Savannah, Georgia, 31405, United States

  • Low Country Cancer Care

    Savannah, Georgia, 31404, United States

  • Loyola University Medical Center

    Maywood, Illinois, 60153, United States

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, 32224-9980, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia, 20007, United States

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia, 20010, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Medical Oncology Hematology Consultants PA

    Newark, Delaware, 19713, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Mercy Clinic-Rolla-Cancer and Hematology

    Rolla, Missouri, 65401, United States

  • Mercy Hospital

    Coon Rapids, Minnesota, 55433, United States

  • Mercy Hospital Joplin

    Joplin, Missouri, 64804, United States

  • Mercy Hospital Saint Louis

    St Louis, Missouri, 63141, United States

  • Mercy Hospital Springfield

    Springfield, Missouri, 65804, United States

  • Metro Minnesota Community Oncology Research Consortium

    Saint Louis Park, Minnesota, 55416, United States

  • Miami Valley Hospital

    Dayton, Ohio, 45409, United States

  • Miami Valley Hospital North

    Dayton, Ohio, 45415, United States

  • Miami Valley Hospital South

    Centerville, Ohio, 45459, United States

  • Minnesota Oncology Hematology PA-Maplewood

    Maplewood, Minnesota, 55109, United States

  • Minnesota Oncology Hematology PA-Woodbury

    Woodbury, Minnesota, 55125, United States

  • Missouri Valley Cancer Consortium

    Omaha, Nebraska, 68106, United States

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

    New York, New York, 10032, United States

  • Nebraska Cancer Research Center

    Lincoln, Nebraska, 68510, United States

  • Nebraska Cancer Specialists - Omaha

    Omaha, Nebraska, 68124, United States

  • Nebraska Hematology and Oncology

    Lincoln, Nebraska, 68506, United States

  • Nevada Cancer Research Foundation NCORP

    Las Vegas, Nevada, 89169, United States

  • New Ulm Medical Center

    New Ulm, Minnesota, 56073, United States

  • North Memorial Medical Health Center

    Robbinsdale, Minnesota, 55422, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Oklahoma Cancer Specialists and Research Institute-Tulsa

    Tulsa, Oklahoma, 74146, United States

  • Oncology Hematology Care Inc-Anderson

    Cincinnati, Ohio, 45230, United States

  • Oncology Hematology Care Inc-Blue Ash

    Cincinnati, Ohio, 45242, United States

  • Oncology Hematology Care Inc-Crestview

    Crestview Hills, Kentucky, 41017, United States

  • Oncology Hematology Care Inc-Eden Park

    Cincinnati, Ohio, 45202, United States

  • Oncology Hematology Care Inc-Healthplex

    Fairfield, Ohio, 45014, United States

  • Oncology Hematology Care Inc-Kenwood

    Cincinnati, Ohio, 45236, United States

  • Oncology Hematology Care Inc-Mercy West

    Cincinnati, Ohio, 45211, United States

  • Oncology Hematology West PC

    Omaha, Nebraska, 68130, United States

  • OptumCare Cancer Care at Fort Apache

    Las Vegas, Nevada, 89148, United States

  • PCR Oncology

    Arroyo Grande, California, 93420, United States

  • Pali Momi Medical Center

    ‘Aiea, Hawaii, 96701, United States

  • Park Nicollet Clinic - Saint Louis Park

    Saint Louis Park, Minnesota, 55416, United States

  • Queen's Cancer Center - Kuakini

    Honolulu, Hawaii, 96817, United States

  • Queen's Cancer Center - Pearlridge

    ‘Aiea, Hawaii, 96701, United States

  • Queen's Medical Center

    Honolulu, Hawaii, 96813, United States

  • Radiation Oncology Centers of Nevada Central

    Las Vegas, Nevada, 89106, United States

  • Radiation Oncology Centers of Nevada Southeast

    Las Vegas, Nevada, 89119, United States

  • Regional West Medical Center Cancer Center

    Scottsbluff, Nebraska, 69361, United States

  • Regions Hospital

    Saint Paul, Minnesota, 55101, United States

  • Reid Health

    Richmond, Indiana, 47374, United States

  • Rice Memorial Hospital

    Willmar, Minnesota, 56201, United States

  • Ridgeview Medical Center

    Waconia, Minnesota, 55387, United States

  • Saint Francis Regional Medical Center

    Shakopee, Minnesota, 55379, United States

  • Saint John's Hospital - Healtheast

    Maplewood, Minnesota, 55109, United States

  • Saint Louis Cancer and Breast Institute-South City

    St Louis, Missouri, 63109, United States

  • Saint Mary's Regional Medical Center

    Reno, Nevada, 89503, United States

  • Sibley Memorial Hospital

    Washington D.C., District of Columbia, 20016, United States

  • Siouxland Regional Cancer Center

    Sioux City, Iowa, 51101, United States

  • Siteman Cancer Center at Saint Peters Hospital

    City of Saint Peters, Missouri, 63376, United States

  • Siteman Cancer Center at West County Hospital

    Creve Coeur, Missouri, 63141, United States

  • Siteman Cancer Center-South County

    St Louis, Missouri, 63129, United States

  • Southeast Nebraska Cancer Center - 68th Street Place

    Lincoln, Nebraska, 68516, United States

  • Sovah Health Martinsville

    Martinsville, Virginia, 24115, United States

  • Springfield Regional Cancer Center

    Springfield, Ohio, 45504, United States

  • Springfield Regional Medical Center

    Springfield, Ohio, 45505, United States

  • Straub Clinic and Hospital

    Honolulu, Hawaii, 96813, United States

  • Summerlin Hospital Medical Center

    Las Vegas, Nevada, 89144, United States

  • TidalHealth Nanticoke / Allen Cancer Center

    Seaford, Delaware, 19973, United States

  • United Hospital

    Saint Paul, Minnesota, 55102, United States

  • Unity Hospital

    Fridley, Minnesota, 55432, United States

  • University Health Network-Princess Margaret Hospital

    Toronto, Ontario, M5G 2M9, Canada

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama, 35233, United States

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, 72205, United States

  • University of Hawaii Cancer Center

    Honolulu, Hawaii, 96813, United States

  • University of Iowa/Holden Comprehensive Cancer Center

    Iowa City, Iowa, 52242, United States

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, 48109, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104, United States

  • Upper Valley Medical Center

    Troy, Ohio, 45373, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

  • Wayne Hospital

    Greenville, Ohio, 45331, United States

  • Wilcox Memorial Hospital and Kauai Medical Clinic

    Lihue, Hawaii, 96766, United States

  • Wright-Patterson Medical Center

    Wright-Patterson Air Force Base, Ohio, 45433, United States

  • Yale University

    New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.